Clinical Trial: Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
Brief Summary: The purpose of this pilot study is to assess the safety and efficacy of Acthar® Gel in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients.
Detailed Summary:
Sponsor: Mamatha Pasnoor, MD
Current Primary Outcome: Number of Participants With Treatment-Related Adverse Events [ Time Frame: 28 Weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Efficacy of study drug [ Time Frame: Change from Baseline to 28 Weeks ]
Original Secondary Outcome: Same as current
Information By: University of Kansas Medical Center
Dates:
Date Received: August 30, 2015
Date Started: August 2015
Date Completion: July 2018
Last Updated: July 15, 2016
Last Verified: July 2016